Tumor burden in metastatic colorectal cancer quantified using deep learning models: Prognostic value and maintenance treatment benefit in the CAIRO3 trial

This exploratory analysis showed that a higher tumor burden, quantified by number or volume, was independently associated with poor outcomes. Patients with lower tumor burden, especially lower TTV, appeared to derive the greatest benefit from maintenance therapy, supporting their potential as predictive biomarkers.